Hester Biosciences to invest Rs 30 cr in new unit
New Delhi : Animal health firm Hester Biosciences plans to invest nearly Rs 30 crore to set up a large unit for products.
"Our next goal is to invest and create our own large animal health products unit and increase capacities at least for a few vaccines in Ahmedabad," Hester Biosciences CEO & Managing Director Rajiv Gandhi said told analysts.
The company plans to invest a little less than Rs 30 crore towards the unit as well as increasing production capacities, he added.
Hester Biosciences has already set up a plant in Nepal which is slated to commence commercial production on November 15, 2016, Gandhi said.
"Animal diagnostics is our next focus area. We hope to launch our animal diagnostics division in the fourth quarter, thereby becoming one the few animal health companies worldwide, covering preventive, curative, growth promoting products as well as diagnostics," website of Hester Biosciences said.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd